| Literature DB >> 28287625 |
Chenglong Yu1,2, Bernhard T Baune3, Julio Licinio1,2, Ma-Li Wong1,2.
Abstract
Major depressive disorder (MDD) is highly prevalent, resulting in an exceedingly high disease burden. The identification of generic risk factors could lead to advance prevention and therapeutics. Current approaches examine genotyping data to identify specific variations between cases and controls. Compared to genotyping, whole-genome sequencing (WGS) allows for the detection of private mutations. In this proof-of-concept study, we establish a conceptually novel computational approach that clusters subjects based on the entirety of their WGS. Those clusters predicted MDD diagnosis. This strategy yielded encouraging results, showing that depressed Mexican-American participants were grouped closer; in contrast ethnically-matched controls grouped away from MDD patients. This implies that within the same ancestry, the WGS data of an individual can be used to check whether this individual is within or closer to MDD subjects or to controls. We propose a novel strategy to apply WGS data to clinical medicine by facilitating diagnosis through genetic clustering. Further studies utilising our method should examine larger WGS datasets on other ethnical groups.Entities:
Mesh:
Year: 2017 PMID: 28287625 PMCID: PMC5347377 DOI: 10.1038/srep44389
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Whole-genome sequencing variation analysis of 25 human subjects.
| Subjects | Gender | Age | Total SNVs | Total INDELs | dbSNP |
|---|---|---|---|---|---|
| MA-Depresson-1 | Female | 35 | 8,348,095 | 522,994 | 4,031,869 |
| MA-Depresson-2 | Female | 30 | 7,921,961 | 513,462 | 3,993,392 |
| MA-Depresson-3 | Female | 41 | 8,037,674 | 514,135 | 3,986,882 |
| MA-Depresson-4 | Female | 32 | 8,021,058 | 511,756 | 3,903,495 |
| MA-Depresson-5 | Female | 45 | 7,839,942 | 511,053 | 4,001,897 |
| MA-Depresson-6 | Female | 38 | 7,834,986 | 516,002 | 4,021,724 |
| MA-Depresson-7 | Female | 36 | 7,935,708 | 512,681 | 3,911,549 |
| MA-Depresson-8 | Female | 59 | 7,694,178 | 514,095 | 3,949,370 |
| MA-Depresson-9 | Female | 41 | 7,778,564 | 520,337 | 3,987,191 |
| MA-Depresson-10 | Female | 31 | 8,073,958 | 526,792 | 4,045,542 |
| MA-Control-1 | Female | 50 | 7,879,192 | 519,009 | 4,042,162 |
| MA-Control-2 | Female | 45 | 6,974,138 | 517,756 | 4,021,858 |
| MA-Control-3 | Female | 39 | 6,911,665 | 526,897 | 3,999,059 |
| MA-Control-4 | Female | 29 | 7,197,066 | 518,675 | 4,011,644 |
| MA-Control-5 | Female | 35 | 7,487,135 | 517,667 | 4,031,216 |
| AU-Depresson-1 | Male | 44 | 3,883,255 | 555,785 | 3,888,831 |
| AU-Depresson-2 | Female | 19 | 3,938,868 | 541,109 | 3,956,682 |
| AU-Depresson-3 | Female | 19 | 3,925,906 | 560,127 | 3,928,997 |
| AU-Depresson-4 | Female | 25 | 3,933,654 | 557,712 | 3,935,804 |
| AU-Depresson-5 | Female | 18 | 3,905,386 | 555,542 | 3,920,378 |
| AU-Control-1 | Female | 20 | 3,898,847 | 569,129 | 3,923,876 |
| AU-Control-2 | Male | 18 | 3,920,681 | 558,496 | 3,903,217 |
| AU-Control-3 | Male | 30 | 3,861,132 | 552,110 | 3,861,584 |
| AU-Control-4 | Female | 18 | 3,922,531 | 568,501 | 3,911,346 |
| AU-Control-5 | Male | 20 | 3,820,520 | 449,055 | 3,773,974 |
MA, Mexican-American; AU, Australian; SNVs, single nucleotide variants; INDELs, small insertions and deletions; dbSNP (the number of SNVs and INDELs that are found in the dbSNP database in NCBI).
Figure 1A hypothetical illustration of the distribution of SNVs on chromosome (chr) 1 of two individuals.
SNV2, SNV4 and SNV6 in person A and SNV3, SNV4 and SNV7 in person B occupy the same respective positions in chr 1.
Figure 2Descriptive statistical distributions of SNVs on all the chromosomes.
(a) The Mexican-American control group. (b) The Mexican-American MDD group.
Figure 3Cluster tree of 25 subjects for different chromosomes.
(a) On chromosome 1. (b) On chromosome 22. (c) On chromosome X.